Summary:
“Paige’s aim is to provide pathologists with innovative, care enhancing technology so they can provide the best possible insights to patients. Through Paige Breast Lymph Node, pathologists can more efficiently identify tumor metastases of any size, including small micrometastases,” said Juan Retamero, MD, medical director of digital pathology transformation at Paige. “The CE-IVD and UKCA marks for Paige Breast Lymph Node are a vital step towards increasing the adoption of our new tool in European hospitals and laboratories.”
Article written by MDDI Staff
06|04|2022
Source:
MD+DI Online
https://www.mddionline.com/digital-health/ai-software-detects-breast-cancer-metastases-lymph-nodes